GlassScriptPhysician profile
Tracy Gasson
NPI 1194153015
$3,684.36
in general payments reported to CMS, 2019-2025
44 companies · $103 in 2025
The $103 reported for 2025 was less than what a typical Adult Health (Nurse Practitioner) provider received nationally (typical 2025 total: $182).
See the full distribution for Adult Health (Nurse Practitioner)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $2,006 · 2022: $1,334 · 2023: $199 · 2024: $42.95 · 2025: $103.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $345.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $344.75 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $812.50 | 2021-2023 | Lynparza |
| E.R. Squibb & Sons, L.L.C. | $264.83 | 2021-2022 | |
| Incyte Corporation | $208.43 | 2021-2022 | |
| Lilly USA, LLC | $207.85 | 2021-2022 | |
| Abbvie INC. | $202.37 | 2021-2025 | |
| Celgene Corporation | $169.35 | 2021-2023 | Reblozyl |
| Seagen INC. | $165.03 | 2021-2022 | |
| Novartis Pharmaceuticals Corporation | $143.23 | 2022-2025 | |
| Eisai INC. | $135.73 | 2021-2022 | |
| Heron Therapeutics, INC. | $133.15 | 2021-2022 | |
| Amgen INC. | $124.03 | 2021-2022 | |
| Daiichi Sankyo INC. | $118.99 | 2021-2022 | |
| Genzyme Corporation | $82.49 | 2021-2022 | |
| Gilead Sciences, INC. | $71.16 | 2021 | |
| Array Biopharma INC | $65.23 | 2021 |
Show all 44 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Tracy Gasson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.